Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$18.5M
total disclosed, rounds participated
Stages
—
About
Forbion is a global venture capital firm with deep expertise in Europe, investing in innovative biotech companies across all stages of (bio-)pharmaceutical drug development. The firm also leverages its biotech expertise to address planetary health challenges through its BioEconomy fund strategy, investing in sustainable solutions in food, agriculture, materials, and environmental technologies. Forbion manages approximately €5 billion across multiple fund strategies and has a strong track record of sourcing, building, and guiding life sciences companies.
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is Forbion Capital Partners' primary investment focus by sector?
- Forbion Capital Partners primarily focuses on the Health Tech & Life Sciences sector, with all of its identified portfolio companies and investment rounds falling within this area.
- Can you name some of Forbion Capital Partners' portfolio companies?
- Forbion Capital Partners' portfolio includes Prilenia Therapeutics, which develops treatments for neurodegenerative diseases, and novoGi, focused on GI disease management.
- What is the typical investment stage for Forbion Capital Partners?
- Forbion Capital Partners has participated in various stages, including A Round, B Round, and F Round investments. They have made two follow-on investments at the B Round stage.
- What was Forbion Capital Partners' most recent investment activity?
- Forbion Capital Partners made an investment in April 2022, following another in November 2021.
- What is the investment range for Forbion Capital Partners?
- Forbion Capital Partners' investment range is between $11M and $68.5M.
- When was Prilenia Therapeutics founded and what is its business model?
- Prilenia Therapeutics, a portfolio company of Forbion Capital Partners, was founded in 2018 and operates with a B2B business model.
- What was the last funding round for Prilenia Therapeutics that Forbion Capital Partners participated in?
- Forbion Capital Partners participated in a B Round for Prilenia Therapeutics, which raised $144.5M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2006 |
|---|